查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1779225

纤维蛋白密封剂市场－全球产业规模、份额、趋势、机会和预测，按产品（液体形式、贴片）、最终用户（门诊手术中心、医院、专科诊所）、按地区和竞争细分，2020-2030 年

Fibrin Sealant Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Liquid Form, Patch), By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics), By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球纤维蛋白密封剂市值为 13.2 亿美元，预计到 2030 年将达到 18.6 亿美元，复合年增长率为 6.09%。纤维蛋白密封剂市场已成为现代外科手术和伤口管理的重要组成部分，在不断发展的医疗技术领域中发挥关键作用。纤维蛋白密封剂，通常称为纤维蛋白胶，是一种止血剂，用于促进血液凝固和密封手术期间和手术后伤口。随着全球外科手术的增加，人口老化、慢性病病例增加和创伤发生率上升，对纤维蛋白密封剂的需求持续成长。该市场的主要驱动力是向微创手术的转变，这需要能够精确、快速起效和有效伤口闭合的工具。纤维蛋白密封剂在这些手术中受到高度重视，因为它们易于使用、具有生物相容性，并且能够显着减少术后併发症。外科医生不仅在计划手术中依赖它们，而且在创伤或事故等紧急情况下也依赖它们，在这些情况下，快速封闭伤口和控制出血至关重要。

市场概览
预测期 2026-2030
2024年市场规模 13.2亿美元
2030年市场规模 18.6亿美元
2025-2030 年复合年增长率 6.09%
成长最快的领域 液体
最大的市场 亚太地区

然而，儘管纤维蛋白封闭剂具有广泛的临床益处，但也面临一些限制。优质封闭剂的高昂成本可能成为其推广应用的障碍，尤其是在发展中国家或预算有限的医疗保健系统。由于许多封闭剂源自人体血浆，其疾病传播风险虽然微乎其微，但值得关注，这引发了人们对其长期安全性的担忧。

关键市场驱动因素

纤维蛋白密封剂在显微外科手术和植入部位皮瓣闭合的新兴应用是纤维蛋白密封剂市场成长的主要因素

主要市场挑战

纤维蛋白密封剂成本高

主要市场趋势

政府资助和医疗品质的改善

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球纤维蛋白密封剂市场的影响

第五章：全球纤维蛋白密封剂市场展望

  • 市场规模和预测
    • 按价值和数量
  • 市场占有率和预测
    • 依类型（液体剂型、贴片）
    • 按最终使用者（门诊手术中心、医院、专科诊所）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：亚太地区纤维蛋白密封剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第七章：欧洲纤维蛋白密封剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第八章：北美纤维蛋白密封剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第九章：南美洲纤维蛋白密封剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲纤维蛋白密封剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特
    • 土耳其
    • 埃及

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章：全球纤维蛋白密封剂市场：SWOT 分析

第 14 章：定价分析

第 15 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代能源的威胁

第 16 章： 大环境分析

第 17 章：竞争格局

  • Johnson and Johnson
  • Baxter International Inc.
  • Nordson Corporation (Nordson Medical)
  • Corza Health Inc
  • Becton Dickinson and Company
  • CSL Behring LLC
  • Grifols SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Vivostat A/S
  • Hemarus Therapeutics Ltd.

第 18 章：策略建议

第19章调查会社について・免责事项

简介目录
Product Code: 18924

Global Fibrin Sealant Market was valued at USD 1.32 Billion in 2024 and is expected to reach USD 1.86 Billion by 2030 with a CAGR of 6.09%. The fibrin sealant market has become an essential component of modern surgical procedures and wound management, playing a pivotal role in the evolving landscape of medical technology. Fibrin sealants, commonly referred to as fibrin glues, are hemostatic agents used to promote blood clotting and seal wounds during and after surgeries. With the global increase in surgical procedures, fueled by an aging population, rising cases of chronic diseases, and higher rates of trauma-the demand for fibrin sealants continues to grow. The key drivers of this market is the shift toward minimally invasive surgeries, which require tools that offer precision, rapid action, and effective wound closure. Fibrin sealants are highly valued in such procedures due to their ease of application, biocompatibility, and ability to significantly reduce post-operative complications. Surgeons rely on them not only in planned operations but also in emergency settings like trauma or accident cases, where quick wound sealing and bleeding control are critical.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.32 Billion
Market Size 2030USD 1.86 Billion
CAGR 2025-20306.09%
Fastest Growing SegmentLiquid
Largest MarketAsia Pacific

However, despite their widespread clinical benefits, fibrin sealants face certain limitations. The high cost of quality sealants can be a barrier to adoption, especially in developing countries or healthcare systems with limited budgets. Since many sealants are derived from human plasma, there is a minimal yet notable risk of disease transmission, prompting concerns about long-term safety.

Key Market Drivers

Emerging Applications of Fibrin Sealant in Microsurgery and Implant Site Flap Closure is Major Factor for Fibrin Sealant Market Growth

The global fibrin sealant market is experiencing substantial growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant, also known as tissue glue or surgical glue, is a biocompatible adhesive derived from human plasma proteins. It has been widely used in various surgical procedures for hemostasis and tissue sealing. Microsurgery is a highly specialized field that involves intricate procedures on very small structures, often using high-powered microscopes. Fibrin sealant has found emerging applications in microsurgery due to its ability to provide precise and controlled tissue adhesion.

In microsurgical applications, the use of fibrin sealant offers several advantages, including reduced operative time, minimal tissue trauma, and improved postoperative recovery. It allows surgeons to achieve hemostasis and close tissues with high precision. Fibrin sealant is increasingly utilized in implant dentistry for site flap closure during dental implant procedures. It plays a crucial role in securing flaps over implant sites, ensuring proper healing and osseointegration. The success of microsurgical and implant procedures heavily relies on the choice of adhesive. Surgeons demand reliable, biocompatible adhesives that can securely close tissues and promote effective healing without causing adverse reactions.

Fibrin sealant is known for its versatility. It can be used in various surgical specialties, including neurosurgery, ophthalmology, plastic surgery, and more, making it a valuable tool in the medical field. In microsurgery and implant site flap closure, precision and safety are paramount. Fibrin sealant provides the controlled and localized tissue adhesion required for successful outcomes while minimizing the risk of complications. Ongoing research and development efforts in the field of fibrin sealant have led to advanced formulations that offer improved adhesion strength, hemostatic properties, and biocompatibility. These advancements contribute to its growing adoption in microsurgery and implant dentistry. The increasing demand for precise and effective tissue adhesives in microsurgery and implant procedures is driving the need for specialized fibrin sealant products. Surgeons and healthcare professionals seek advanced solutions to enhance surgical outcomes.

The global fibrin sealant market is experiencing robust growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant has become an essential tool in achieving secure tissue adhesion and promoting healing in delicate surgical procedures. As the awareness of its benefits in microsurgery and implant dentistry continues to grow, the market for fibrin sealant is expected to thrive. Manufacturers and suppliers in this market must remain at the forefront of technology and innovation to meet the evolving demands of surgeons and healthcare professionals, ensuring continued growth and improved surgical outcomes worldwide.

Key Market Challenges

High Cost of Fibrin Sealants

The high cost of fibrin sealants represents a substantial obstacle to the growth of the global Fibrin Sealant market. Fibrin sealants are biologically derived adhesives used in surgical procedures to facilitate hemostasis, tissue sealing, and wound closure. Their effectiveness and safety have made them invaluable in various surgical applications, including cardiovascular, orthopedic, and general surgery. However, the production and processing of fibrin sealants involves complex biotechnological processes and stringent quality control, resulting in elevated production costs.

The high cost of fibrin sealants can strain healthcare budgets, deter some healthcare facilities from adopting these products, and limit market growth potential. Additionally, affordability concerns can lead to a preference for alternative hemostatic and tissue sealing solutions, further hampering market expansion.

To address this challenge and stimulate growth in the Fibrin Sealant market, manufacturers must explore strategies to optimize production processes, improve cost-efficiency, and collaborate with healthcare providers to showcase the long-term benefits and cost-effectiveness of fibrin sealant use. By making these vital surgical aids more accessible, the market can continue to advance in the field of medical procedures and surgical interventions.

Key Market Trends

Government Funding and Improvement in the Quality of Healthcare

Advancements in bonding technologies are a fundamental trend driving the growth of the global Fibrin Sealant market. As industries continue to evolve, there is a growing demand for Fibrin Sealant that offer improved bonding capabilities, versatility, and efficiency. These advancements are not only transforming traditional bonding processes but also expanding the applications of Fibrin Sealant across various sectors.

The development of innovative bonding technologies includes the formulation of adhesive products with enhanced chemical compositions, allowing them to bond a wider range of plastic substrates effectively. Additionally, improvements in curing mechanisms, such as UV curing and cyanoacrylate technology, have accelerated bonding speeds and enhanced the overall performance of Fibrin Sealant.

These advancements are particularly crucial in industries like automotive, electronics, and medical devices, where plastic components play a significant role. As manufacturers seek reliable, high-performance bonding solutions to improve product quality and assembly efficiency, the global Fibrin Sealant market is poised for substantial growth. Companies that invest in cutting-edge bonding technologies and adapt to evolving industry demands are well-positioned to capitalize on this transformative trend.

Key Market Players

  • Johnson and Johnson
  • Baxter International Inc.
  • Nordson Corporation (Nordson Medical)
  • Corza Health Inc
  • Becton Dickinson and Company
  • CSL Behring LLC
  • Grifols SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Vivostat A/S
  • Hemarus Therapeutics Ltd

Report Scope:

In this report, the Global Fibrin Sealant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fibrin Sealant Market, By Type:

  • Liquid Form
  • Patch

Fibrin Sealant Market, By End User:

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Fibrin Sealant Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Turkiye
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fibrin Sealant Market.

Available Customizations:

Global Fibrin Sealant market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Fibrin Sealant Market

5. Global Fibrin Sealant Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Liquid Form, Patch)
    • 5.2.2. By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. Asia Pacific Fibrin Sealant Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Fibrin Sealant Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. India Fibrin Sealant Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Australia Fibrin Sealant Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User
    • 6.3.4. Japan Fibrin Sealant Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By End User
    • 6.3.5. South Korea Fibrin Sealant Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By End User

7. Europe Fibrin Sealant Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Fibrin Sealant Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Fibrin Sealant Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Spain Fibrin Sealant Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Fibrin Sealant Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. United Kingdom Fibrin Sealant Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. North America Fibrin Sealant Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Fibrin Sealant Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Mexico Fibrin Sealant Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Canada Fibrin Sealant Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User

9. South America Fibrin Sealant Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fibrin Sealant Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Fibrin Sealant Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Fibrin Sealant Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Fibrin Sealant Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1.By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1.By Type
    • 10.2.2.By End User
    • 10.2.3.By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fibrin Sealant Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Fibrin Sealant Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Fibrin Sealant Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Kuwait Fibrin Sealant Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkiye Fibrin Sealant Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value & Volume
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Type
        • 10.3.5.2.2. By End User
    • 10.3.6. Egypt Fibrin Sealant Market Outlook
      • 10.3.6.1. Market Size & Forecast
        • 10.3.6.1.1. By Value & Volume
      • 10.3.6.2. Market Share & Forecast
        • 10.3.6.2.1. By Type
        • 10.3.6.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends and Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Fibrin Sealant Market: SWOT Analysis

14. Pricing Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Sources

16. PESTLE Analysis

17. Competitive Landscape

  • 17.1. Johnson and Johnson
    • 17.1.1.Business Overview
    • 17.1.2.Company Snapshot
    • 17.1.3.Products & Services
    • 17.1.4.Financials (In case of listed companies)
    • 17.1.5.Recent Developments
    • 17.1.6.SWOT Analysis
  • 17.2. Baxter International Inc.
  • 17.3. Nordson Corporation (Nordson Medical)
  • 17.4. Corza Health Inc
  • 17.5. Becton Dickinson and Company
  • 17.6. CSL Behring LLC
  • 17.7. Grifols SA
  • 17.8. Shanghai RAAS Blood Products Co., Ltd.
  • 17.9. Vivostat A/S
  • 17.10. Hemarus Therapeutics Ltd.

18. Strategic Recommendations

19. About us & Disclaimer